Published in Science on January 21, 1966
Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet (1993) 8.39
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res (2001) 6.93
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science (1990) 5.49
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer (2003) 4.14
Estimation of the number of sex alleles and queen matings from diploid male frequencies in a population of Apis mellifera. Genetics (1977) 3.98
The learning curve for laparoscopic colorectal surgery. Preliminary results from a prospective analysis of 1194 laparoscopic-assisted colectomies. Arch Surg (1997) 3.57
Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ (1999) 3.50
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol (2004) 3.49
Evolution of Escherichia coli during growth in a constant environment. Genetics (1987) 3.44
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A (1990) 3.28
Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet (1999) 3.24
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli. Genetics (1994) 3.19
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) (1986) 3.14
Coronary vasospasm induced by subcutaneous sumatriptan. BMJ (1992) 3.13
RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J (2000) 3.12
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations. Nature (1983) 3.03
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun (1990) 2.77
Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coli. Mol Biol Evol (1998) 2.69
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res (2001) 2.65
Polycystic ovaries--a common finding in normal women. Lancet (1988) 2.58
A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry (1991) 2.57
Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med (1989) 2.56
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Determinants of patient satisfaction and willingness to return with emergency care. Ann Emerg Med (2000) 2.49
Admixture studies and the detection of selection. Science (1973) 2.41
Relative fitness can decrease in evolving asexual populations of S. cerevisiae. Nature (2006) 2.40
Arm edema in breast cancer patients. J Natl Cancer Inst (2001) 2.35
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ (1988) 2.29
Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev (2007) 2.26
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res (2001) 2.18
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol (2011) 2.13
Case-mix adjustment of the National CAHPS benchmarking data 1.0: a violation of model assumptions? Health Serv Res (2001) 2.10
Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group. Osteoporos Int (1991) 2.07
Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes. J Exp Med (2000) 2.07
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet (2001) 2.05
Proteasome inhibition measurements: clinical application. Clin Chem (2000) 2.04
Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol (1985) 2.00
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Estimation of phylogenetic relationships from DNA restriction patterns and selection of endonuclease cleavage sites. Proc Natl Acad Sci U S A (1982) 1.98
Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J Bacteriol (1990) 1.94
The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res (1999) 1.94
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. J Biol Chem (1991) 1.90
Distinct roles of two conserved Staufen domains in oskar mRNA localization and translation. EMBO J (2000) 1.87
The maintenance of Plasmid-containing organisms in populations of Escherichia coli. J Gen Microbiol (1981) 1.85
Optic neuropathy in patients with glioblastoma receiving bevacizumab. Neurology (2009) 1.84
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol (2001) 1.82
Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev (1980) 1.76
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A (1998) 1.69
Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys (2001) 1.67
Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev (2007) 1.67
Fibromyalgia: a risk factor for osteoporosis. J Rheumatol (1999) 1.63
Nonoperative management of posterior tibial tendon dysfunction. Foot Ankle Int (1996) 1.61
Evaluation of outpatient geriatric assessment: a randomized multi-site trial. J Am Geriatr Soc (1995) 1.58
Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology (2006) 1.55
Fixed drug combinations and the displacement of bilirubin from albumin. Pediatrics (1971) 1.54
Cysteine usage increases the need for acetate in neonates who receive total parenteral nutrition. Am J Clin Nutr (1991) 1.53
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle. J Clin Oncol (2005) 1.50
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther (1998) 1.46
A community-level HIV prevention intervention for inner-city women: results of the women and infants demonstration projects. Am J Public Health (2000) 1.46
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44
Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol (1985) 1.44
Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab (2006) 1.41
Behavioral control by an imprinted stimulus. J Exp Anal Behav (1966) 1.41
Juvenile spring eruption of the ears: a probable variant of polymorphic light eruption. Br J Dermatol (1991) 1.40
Wnt pathway regulation in chronic renal allograft damage. Am J Transplant (2009) 1.39
The Wake-up Call. West J Med (1993) 1.39
Orientation of histopathology specimens. Br J Oral Maxillofac Surg (2004) 1.38
ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J Immunol (2000) 1.38
Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab (2006) 1.38
Event-related potentials in schizophrenia: their biological and clinical correlates and a new model of schizophrenic pathophysiology. Schizophr Res (1991) 1.38
The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: results from a survey of 500 cancer patients. Public Health (2010) 1.36
Identification of vertebral fractures: an update. Osteoporos Int (2005) 1.34
Fitness effects of Ty transposition in Saccharomyces cerevisiae. Genetics (1992) 1.33
Estimation of expected number of rare alleles of a locus and calculation of mutation rate. Proc Natl Acad Sci U S A (1978) 1.32
Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci (2003) 1.32
The relationship between enzyme activity, cell geometry, and fitness in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1975) 1.31
Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol (1991) 1.29
Population studies in microorganisms. I. Evolution of diploidy in Saccharomyces cerevisiae. Genetics (1974) 1.28
Physiological characterization of adaptive clones in evolving populations of the yeast, Saccharomyces cerevisiae. Genetics (1985) 1.28
Association between amputation, arthritis and osteopenia in British male war veterans with major lower limb amputations. Clin Rehabil (1998) 1.28
Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br Med J (Clin Res Ed) (1984) 1.26
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J Infect Dis (1991) 1.26
Structure of evolving populations of Saccharomyces cerevisiae: adaptive changes are frequently associated with sequence alterations involving mobile elements belonging to the Ty family. Proc Natl Acad Sci U S A (1986) 1.26
Tetracycline-resistant gonococci in UK. Lancet (1988) 1.26
The response of general practitioners to the threat of violence in their practices: results from a qualitative study. Fam Pract (2006) 1.25
Collateral behavior of the pigeon during conditioned suppression of key pecking. J Exp Anal Behav (1971) 1.25
Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. J Clin Invest (1974) 1.24
Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res (2000) 1.24
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Ann Oncol (2007) 1.24
New insights into proteasome function: from archaebacteria to drug development. Chem Biol (1995) 1.23
26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J Cell Biochem (2001) 1.23
The population biology and evolutionary significance of Ty elements in Saccharomyces cerevisiae. Genetica (1992) 1.23
Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res (1991) 1.22
Bone marrow lesions predict increase in knee cartilage defects and loss of cartilage volume in middle-aged women without knee pain over 2 years. Ann Rheum Dis (2008) 1.22